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1. Introduction 
At present there is convincing evidence of alteration 
of the RNA population in tumors [l-6] . Study of the 
alterations in RNA population after carcinogen treat- 
ment before the appearance of the tumor is of great 
importance for understanding carcinogenesis mechanisms 
There are many papers dealing with the effect of 
different carcinogens on the RNA synthesis, both 
inhibitory and stimulating [7]. At present DNA-RNA 
hybridization is the most sensitive technique available 
for determining the differences in genomic expression. 
In cancer research this technique has been used to 
compare the nuclear and cytoplasmic RNA obtained 
from the normal tissue with that of the liver tissue 
undergoing carcinogenesis. The results of competitive 
hybridization studies obtained by Shearer and authors 
[8-IO] show that there are some RNA species in the 
liver cell cytoplasm of rat with carcinogen diet which 
in the normal liver are found in the nuclei only. The 
authors explain this fact by alterations in RNA transport 
from nucleus to cytoplasm. This view is confirmed by 
competitive hybridization of nuclear and cytoplasmic 
RNA observed by Garrett and coauthors [ 111. However 
their experiments were carried out with more than 6 
days carcinogen diet. Also hybridization conditions 
employed (low nucleic acid concentration and short 
incubation times) provided evidence on the hybridi- 
zation of RNA with the rapidly reassociating repeated 
DNA sequences only [ 12- 1.51. Nevertheless none 
of the previous experimentators which measured the 
RNA-DNA hybridization of higher organisms ob- 
served hybrids between RNA and nonrepeated DNA 
sequences in case of cancer research. 
330 
So our task was to study the effect of hepatotropic 
carcinogen on a population of RNAs in different stages 
after a short treatment. The present work was under- 
taken to investigate the effects of 4dimethylamino- 
azobenzene on the transcription of rat liver unique 
DNA after one day treatment. 
2. Materials and methods 
130-150 g Male rats were used. 4-Dimethylamino- 
azobenzene (DAB) in oil (50 mg/200 g body wt) was 
injected intraperitoneally 24 h before the animals were 
sacrificed. 40 min before slaughter [14C] erotic acid 
(100 &i/rat) was administered to both control and 
carcinogen-treated rats. 
Nuclear RNA was extracted with hot phenol at the 
temperature interval of 65-85°C [16] and treated with 
DNAase (Worthington, RNAase-free) and pronase 
(Serva). This fraction of RNA mostly consists of the 
precursor of information RNA. Specific radioactivity 
of RNA preparations was 1500-2000 counts /min/ 
l.lg. 
DNA was isolated by a modificated phenol- 
detergent procedure [ 171 and treated with RNAase 
(Reanal) and pronase. DNA was sheared in 0.14 M 
NaCl solution by sonication to fragments of -500 
nucleotide pairs, sedimenting at 7 S. After denatu- 
ration (20 min in boiling water bath) and reassociation 
to Cot = 100 in 0.12 M phosphate buffer, pH 6.8 
(PB) at 60°C DNA was separated into single- and 
double-stranded fragments on hydroxyapatite columns 
according to Britten’s procedure [ 121. Slowly 
reassociating DNA which had renatured at Cot > 100 
was eluted with 0.12 M PB. 
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DNA-RNA hybridizations were run at 66°C in 
0.24 M PB solution at various Cot values using 
excess of rat liver DNA [ 151. Hybridization samples 
were treated with RNAase (20 pg/ml, 15 min). After 
precipitation with cold 5% trichloracetic acid hybrids 
were collected on membrane filters (HUFS, 
Czechoslovakia). 
3. Results and discussion 
Figure 1 illustrates the hybridization of slowly 
reassociating unique DNA sequences with controlRNA 
and RNA from DAB-treated livers, the latter hybridiz- 
ing to markedly smaller extent. This difference in hy- 
bridization values has been reproducibly demonstrated 
using at least two different RNA preparations. The 
experimental points of one curve differ from-those of 
the other curve at a confidence level of 0.99 (p < 0.01). 
The above data thus seem to suggest hat DAB induces 
specific alterations in the nuclear RNA population. The 
observed changes might result from changing the 
intensity of transcription of DNA sites that are active 
in the control. 
To investigate the peculiarities of changes in the popud 
lation of RNA synthesized on unique DNA sequences, 
competitive hybridization studies were performed. 
The competitive efficiency of unlabeled liver nuclear 
RNA from control rats and those treated for one day 
with DAB has been determined. Results of competition 
studies are shown in fig.2. For these studies duplicate 
Fig. 1. Hybridization capacity of nuclear [ I4 C] RNA isolated 
’ from livers of control (1) and DAB-treated rats (2) with the 
fraction of slowly renaturing DNA. 2-3 pg [“Cl RNA was 
incubated in 0.1-0.2 ml of 0.24 M PB, the ratio 
DNA/RNA = 150. Abscissa: Cot value. Ordinate: percent 
of hybridization. 
Gnvlcl;tue RNAjV-RNA .!&&e RNA/'T-RNA 
Fig.2. Competitive hybridization. Comparison of normal 
liver RNA (1) with that from liver nuclei of rats treated with 
DAB for 1 day. (2) [ 14C] -Labelled RNA from normal (a) 
and DAB-treated liver (b), 5 pg, was incubated in 0.2 ml of 
0.24 MPB, pH 6.8, with the fraction of unique DNA, 
300 Mg, Cot = 5000, in the presence of increasing amounts of 
unlabelled competiting RNA. (3) Unspectic hybridization; 
competitor-cytoplasmic RNA from E. coli. Abscissa: the 
ratio of the amount of competitive RNA to [‘VI RNA in a 
hybridization sample. Ordinate: percent of competitive 
hybridization (hybridization in the absence of competitor is 
taken for 100%). 
samples were run at each competition point. At the 
highest levels of competition the experimental points 
differ from those of the other curve withp < 0.02 and 
0.05 in fig.2a and 2b correspondingly. Figure 2a shows 
that after one day of treatment nuclear RNA has less 
competition efficiency for control nuclear RNA than 
the control RNA. These results as the data shown in 
fig.1 suggest hat carcinogen induces a decrease in the 
relative amount of RNAs transcribed from unique DNA 
sequences in liver cells, namely partial blocking of 
some unique DNA sites transcribed in the control is 
observed. 
Results of analoguous competition studies are 
shown in fig.2b. The hybridization curves differ 
significantly, this difference demonstrating that after 
one day of treatment nuclear RNA has more compe- 
tition efficiency for the same RNA, than the control 
RNA. These data seem to suggest hat carcinogen 
induces the appearance of some new RNA compo- 
nents which are not detectable in control, namely 
partial deblocking of some unique DNA sites 
is observed. 
Thus in liver nuclei one day treatment of DAB in- 
duces blocking of some unique DNA sites. Along with 
these changes the partial deblocking of the other unique 
DNA sites seems to occur. The observed changes in 
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the RNA population under the action of DAB might 
be associated with the alterations of some tissue 
specific syntheses characteristic of the primary effect 
of carcinogens and of many tumors [7]. The activa- 
tion of some unique DNA sequences might be associ- 
ated for example with the appearing of proteins which 
are normally characteristic of embryo cells. Further 
investigations for clarifying the nature of alterations 
observed after short time of carcinogen treatment 
in the process of transcription are required. 
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